美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trans-Lux Corp.

0.0111

0.0000

成交量：- -

成交額：- -

市值：14.98萬

市盈率：-0.04

高：0.0111

開：0.0111

低：0.0111

收：0.0111

52周最高：0.3500

52周最低：0.0111

股本：1,349.63萬

流通股本：604.42萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.2578

每股收益(LYR):-0.2578

淨資產收益率：83.30%

總資產收益率：-23.34%

市淨率：-0.01

市盈率(LYR):-0.04

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

BUZZ-晨星預計澳大利亞泰利克斯製藥公司利潤率將擴張，維持收入預期

BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TNLX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TNLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TNLX\",,,,,undefined,":{"symbol":"TNLX","market":"US","secType":"STK","nameCN":"Trans-Lux Corp.","latestPrice":0.0111,"timestamp":1779389460000,"preClose":0.0111,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":6044195,"shares":13496276,"eps":-0.25778,"marketStatus":"交易中","change":0,"latestTime":"05-21 14:51:00 EDT 延時","open":0.0111,"high":0.0111,"low":0.0111,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.25778,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1779393600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0111,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TNLX\",,,,,undefined,":{"symbol":"TNLX","floatShares":6044195,"roa":"-23.34%","roe":"83.30%","lyrEps":-0.25778,"shares":13496276,"dividePrice":0,"high":0.0111,"amplitude":0,"preClose":0.0111,"low":0.0111,"week52Low":0.0111,"pbRate":"-0.01","psRate":"0.01","week52High":0.35,"institutionHeld":0,"latestPrice":0.0111,"eps":-0.25778,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.25778,"open":0.0111,"prevYearClose":0.06,"prevWeekClose":0.0111,"prevMonthClose":0.0111,"prevQuarterClose":0.11,"fiveDayClose":0.0111,"twentyDayClose":0.0111,"sixtyDayClose":0.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TNLX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TNLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TNLX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TNLX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625965636","title":"BUZZ-晨星預計澳大利亞泰利克斯製藥公司利潤率將擴張，維持收入預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2625965636","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625965636?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 03:59","pubTimestamp":1775591947,"startTime":"0","endTime":"0","summary":"4月7日 - ** 晨星预计泰利克斯制药公司TLX.AX的息税前利润率到中期将扩张29%。** TLX周二公布  季度集团收入为2.3亿美元，重申2026年收入预期为9.5亿-9.7亿美元。** 晨星公司表示：\"泰利克斯有望实现我们对其 2026 年 9.6 亿美元的收入预期，我们维持这一预期不变。\"** 投资者研究公司称，核心前列腺癌成像的增长将继续支撑泰利克斯的业绩表现** 晨星公司预计，随着 2026 年 TLX 的管线产品 Pixclara的成功上市，该公司的发展势头将持续下去。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4S40Q1FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4157","TNLX","LU2065731478.USD","TLX.AU","LU1878469433.USD","BK4112","MORN","BK7067","BK4598"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604055151","title":"BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604055151","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604055151?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 08:39","pubTimestamp":1768869597,"startTime":"0","endTime":"0","summary":"1月20日 - ** 澳大利亚泰利克斯制药公司TLX.AX股价上涨6.3%至11.99澳元，创下近两个月来最大盘中涨幅。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4S3YL01L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","TLX.AU","BK7067","00512","TNLX","BK4157"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TNLX\",params:#limit:6,delay:false,,,undefined,":[]}}